Elevated soluble CD14-subtype (PRESEPSIN; P-SEP) levels in rheumatoid arthritis (RA) patients with bacterial infection

Soichiro TsujiDepartment of Rheumatology and Allergology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan,

Ayako KitatoubeDepartment of Clinical Research, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan, and

Akie Kikuchi-TauraDepartment of Clinical Research, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan, and

Eri OguroDepartment of Rheumatology and Allergology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan,

Minoru ShigesakaDepartment of Rheumatology and Allergology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan,

Yasutaka OkitaDepartment of Rheumatology and Allergology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan,

Takashi ShimizuDepartment of Rheumatology and Allergology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan,

Takuro NiiDepartment of Rheumatology and Allergology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan,

Satoru TeshigawaraDepartment of Rheumatology and Allergology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan,

Eriko TanakaDepartment of Rheumatology and Allergology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan,

Yoshinori HaradaDepartment of Rheumatology and Allergology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan,

Masato MatsushitaDepartment of Rheumatology and Allergology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan,

Jun HashimotoDepartment of Rheumatology and Allergology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan,

Shiro OhshimaDepartment of Clinical Research, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan, and Correspondence[email protected]

Gaku TakahashiDepartment of Critical Care Medicine and Disaster Medicine Medicine, Iwate Medical University, Uchimaru, Morioka, Japan

Shigeatsu EndoDepartment of Critical Care Medicine and Disaster Medicine Medicine, Iwate Medical University, Uchimaru, Morioka, Japan

Yukihiko SaekiDepartment of Clinical Research, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan, and

show all

References

Yaegashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother. 2005;11(5):234–8.
PubMedGoogle Scholar
Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a maker of for the diagnosis and severity of sepsis in systemic inflammatory response syndrome. J Infect Chemother. 2011;17(6):764–9.
PubMed Web of Science ®Google Scholar
Mussap M, Noto A, Cibecchini F, Fanos V. The importance of biomarkers in neonatology. Semin Fetal Neonatal Med. 2013;18(1):56–64.
PubMed Web of Science ®Google Scholar
Arai Y, Mizugishi K, Nonomura K, Naitoh K, Takaori-Kondo A, Yamashita K. Phagocytosis by human monocytes is required for the secretion of presepsin. J Infect Chemother. 2015;21:564–9.
PubMed Web of Science ®Google Scholar
Liu B, Chen Y-X, Yin Q, Zhao Y-Z, and Li C-S. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Critical Care. 2013;17:244.
PubMed Web of Science ®Google Scholar
Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012;18(6):891–7.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Elevated soluble CD14-subtype (PRESEPSIN; P-SEP) levels in rheumatoid arthritis (RA) patients with bacterial infection

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Elevated soluble CD14-subtype (PRESEPSIN; P-SEP) levels in rheumatoid arthritis (RA) patients with bacterial infection

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date